Medtronic (MDT) Revenue — Quarter Ended Jan 23, 2026
Revenue increased compared to the prior quarter and rose sharply versus the same quarter last year. The company attributed the performance to broad-based growth across its portfolio.
Key takeaway
Quarter ended Jan 23, 2026 · FY2026 Q3
Revenue increased compared to the prior quarter and rose sharply versus the same quarter last year. The company attributed the performance to broad-based growth across its portfolio.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$9B
Revenue reported for this quarter.
Quarter-over-quarter
+0.6%
Change from the immediately preceding quarter.
Year-over-year
+8.7%
Change from the comparable year-ago quarter.
Trailing four quarters
$35.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Apr 25, 2025 | $8.9B | +3.9% |
| Jul 25, 2025 | $8.6B | +8.4% |
| Oct 24, 2025 | $9B | +6.6% |
| Jan 23, 2026 | $9B | +8.7% |
Revenue performance
The reported revenue reflects a sequential improvement from the immediately preceding quarter. The year-over-year comparison shows a notable acceleration in revenue growth.
Quarterly comparison
Compared to the prior quarter, revenue moved higher, continuing an upward trend. Relative to the same quarter one year earlier, revenue was substantially higher, driven by sustained demand.
What to watch
Monitor the impact of competitive pressures and regulatory developments on future revenue trends.